Clinical Trial Update: To Investigate the Efficacy and Safety of Individualized Doses of BioChaperone Insulin Lispro in Comparison to Humalog® U-100 in Patients With Type 1 Diabetes Mellitus [Phase 1]

View source ↗

Summary

Phase 1 study comparing individualized doses of BioChaperone Insulin Lispro with Humalog U-100 in patients with Type 1 Diabetes Mellitus; the trial status is co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• BioChaperone Insulin Lispro (insulin lispro)
• Humalog U-100 (insulin lispro)

Snippet

Sponsor: Adocia | Conditions: Type 1 Diabetes Mellitus | Phase 1 | Status: COMPLETED